製藥和生物技術領域的生產和供應協議（2021-2026）

全球生物製藥產業生產與供應合作關係基準分析

"製藥和生物技術領域的生產和供應協議" 報告對全球生命科學產業的生產和供應合作關係進行了全面分析。該報告專為業務拓展、授權和營運專業人士設計，深入剖析了企業如何建立生產協議、協商財務條款以及建立供應關係，以支援藥物研發和商業化。

這份經過全面修訂和更新的報告，提供了從 Current Agreements 的協議和合作關係資料庫中提取的最新發布的生產和供應協議的完整清單。每份合約記錄都包含可用的財務信息，以及指向詳細線上合約記錄和合約文件的鏈接，這些文件將在發布後提交給監管機構。

透過結合詳細的合約資料、財務基準和實際合約文件的存取權限，本報告提供了寶貴的見解，可幫助您評估潛在合作夥伴、建立供應協議並協商更有效的生產合作關係。

主要優勢

• 顯著縮短研究時間

您無需搜尋多個資料庫、新聞稿和監管文件，即可存取統一的生產和供應協議資料庫。

• 生產與供應協議結構基準分析

您可以了解製藥和生技公司如何建立其生產和供應合作關係，包括責任、分工和長期供應協議。

• 自信地分析財務條款

您可以查看已揭露的財務條款和交易價值，並對類似的商業結構進行基準分析。生產協議。

• 查閱實際合約文件

如有需要，您可以查閱已向美國證券交易委員會 (SEC) 提交的生產和供應協議，深入了解實際合作關係背後的詳細合約條款。

• 識別主要生產和供應承包公司

識別生產合作關係中最活躍的公司，並分析其外包和供應鏈策略。

• 追蹤產業趨勢

依公司、治療領域和技術類型分析生產和供應承包趨勢，了解外包和生產策略的演變。

回報內容

生產與供應承包趨勢分析

生產和供應合約結構概述

主要生產和供應合約回顧價值

最活躍的生產和供應合約公司簡介

依公司、治療領域、技術類型和行業分類的交易詳細分析

目前：包含協議資料庫中註冊的生產和供應協議的綜合合約目錄。

線上交易記錄和合約文件的連結（如有）

基於實際合約的盡職調查見解

本報告使用戶能夠評估關鍵的合作條款，例如：

• 生產責任與生產承諾
• 供應條款和商業義務
• 財務支付結構與定價機制
• 獨家條款與地理供應權
• 品質控制與監管合規責任
• 合約期限和終止條款
• 合約文件提供了合作夥伴之間協商的詳細條款的關鍵資訊。 這些資訊通常無法在新聞稿或傳統交易資料庫中找到。
• 本報告的重要性
• 生產和供應合作關係對於醫藥和生物技術產品的成功開發和商業化至關重要。企業越來越依賴外部合作夥伴來擴大生產規模、提升產能並取得專業製造技術。 本報告提供全面的交易數據、財務基準以及實際合約文件的存取權限，從而提供建立更強大的生產合作夥伴關係、評估外包策略以及談判有效供應合約所需的洞察。

目錄

摘要整理

第一章：引言

第二章：製造與供應交易趨勢

• 引言
• 製造與供應合約的定義
• 2021年以來製造與供應合約的趨勢
  • 依年份劃分的製造與供應合約
  • 依研發階段劃分的製造與供應合約
  • 依行業劃分的製造與供應合約
  • 依治療領域劃分的製造與供應合約
  • 依技術類型劃分的製造與供應合約
  • 依最活躍公司劃分的製造與供應合約
• 簽訂製造與供應合作協議的原因
• 製造業的未來製造與供應合約

第三章 製造與供應合約架構概述

• 引言
• 製造與供應合約結構

第四章 - 主要製造與供應合約

• 引言
• 依價值排名的頂級製造與供應合同

第五章 - 最活躍的25家製造與供應合約公司

• 引言
• 最活躍的25家製造與供應合約公司

第六章 - 製造與供應合約（含合約目錄）

• 引言
• 依合約類型分類的製造與供應合約
• 交易目錄
• 依公司分類的製造與供應合約交易目錄（AZ）
• 製造與供應合約交易目錄依治療領域分類
• 交易目錄 - 依技術類型分類的生產和供應合約
• 關於研究公司
• 當前合作夥伴關係
• 當前合約
• 近期合作夥伴發布的報告標題

Benchmark Manufacturing and Supply Partnerships Across the Global Biopharma Industry

The Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology report provides a comprehensive analysis of manufacturing and supply partnerships across the global life sciences industry. Designed for business development, licensing, and operations professionals, the report delivers detailed insight into how companies structure manufacturing agreements, negotiate financial terms, and establish supply relationships to support drug development and commercialization.

Fully revised and updated, the report provides a comprehensive listing of manufacturing and supply deals announced in recent years, drawn from the Current Agreements deals and alliances database. Each deal record includes financial information where available and links to detailed online deal records and contract documents filed with regulators when publicly disclosed.

By combining detailed deal data, financial benchmarking, and access to real contract documents, the report provides valuable intelligence for evaluating potential partners, structuring supply agreements, and negotiating more effective manufacturing partnerships.

Key Benefits

• Save Significant Research Time

Access a consolidated database of manufacturing and supply agreements instead of searching multiple databases, press releases, and regulatory filings.

• Benchmark Manufacturing and Supply Deal Structures

Understand how pharmaceutical and biotechnology companies structure manufacturing and supply partnerships, including responsibilities, operational roles, and long-term supply arrangements.

• Analyze Financial Terms with Confidence

Review disclosed financial terms and transaction values to benchmark the commercial structure of comparable manufacturing agreements.

• Access Real Contract Documents

Where available, explore SEC-filed manufacturing and supply agreements, providing deeper insight into the detailed contractual provisions behind real-world partnerships.

• Identify Leading Manufacturing and Supply Dealmakers

Discover which companies are most active in manufacturing partnerships and analyze their outsourcing and supply chain strategies.

• Track Industry Trends

Analyze manufacturing and supply dealmaking trends across companies, therapeutic areas, and technology types to understand how outsourcing and production strategies are evolving.

What's Included in the Report

Analysis of manufacturing and supply dealmaking trends

Overview of manufacturing and supply agreement structures

Review of the leading manufacturing and supply deals by value

Profiles of the most active manufacturing and supply dealmakers

Detailed analysis of deals organized by company, therapeutic area, technology type, and industry sector

A comprehensive deal directory covering manufacturing and supply agreements recorded in the Current Agreements database

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual manufacturing and supply contracts, the report enables users to evaluate key partnership provisions such as:

• Manufacturing responsibilities and production commitments
• Supply terms and commercial obligations
• Financial payment structures and pricing mechanisms
• Exclusivity provisions and territorial supply rights
• Quality control and regulatory compliance responsibilities
• Contract duration and termination provisions
• Contract documents provide critical insight into the detailed terms negotiated between partners-information that is often not available in press releases or traditional deal databases.
• Why This Report Matters
• Manufacturing and supply partnerships are essential to the successful development and commercialization of pharmaceutical and biotechnology products. Companies increasingly rely on external partners to scale production, expand capacity, and access specialized manufacturing technologies.
• By providing comprehensive deal data, financial benchmarking, and access to real contract documents, this report delivers the intelligence needed to structure stronger manufacturing partnerships, evaluate outsourcing strategies, and negotiate more effective supply agreements.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals since 2021
  • 2.3.1. Manufacturing and supply dealmaking by year
  • 2.3.2. manufacturing and supply dealmaking by phase of development
  • 2.3.3. Manufacturing and supply dealmaking by industry sector
  • 2.3.4. Manufacturing and supply dealmaking by therapy area
  • 2.3.5. Manufacturing and supply dealmaking by technology type
  • 2.3.6. Manufacturing and supply dealmaking by most active company
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements
• Figure 3: Manufacturing and supply deals signed at each phase of development
• Figure 4: Manufacturing and supply deals by industry sector
• Figure 5: Manufacturing and supply deals by therapy area
• Figure 6: Manufacturing and supply deals by technology type
• Figure 7: Top 25 most active manufacturing and supply dealmakers
• Figure 8: Top manufacturing and supply deals by value
• Figure 9: Most active manufacturing and supply dealmakers